PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.75%
Revenue growth above 1.5x 3391.T's 0.98%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
1.77%
Gross profit growth above 1.5x 3391.T's 0.02%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
4.04%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
15.41%
Operating income growth above 1.5x 3391.T's 0.58%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
13.61%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
13.59%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
13.59%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.02%
Share count expansion well above 3391.T's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.02%
Diluted share reduction more than 1.5x 3391.T's 0.61%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-100.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
160.73%
Similar 10Y revenue/share CAGR to 3391.T's 174.45%. Walter Schloss might see both firms benefiting from the same long-term demand.
56.92%
5Y revenue/share CAGR above 1.5x 3391.T's 26.20%. David Dodd would look for consistent product or market expansions fueling outperformance.
34.46%
3Y revenue/share CAGR above 1.5x 3391.T's 11.94%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
138.65%
Net income/share CAGR 1.25-1.5x 3391.T's 101.29%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
37.21%
5Y net income/share CAGR above 1.5x 3391.T's 14.38%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-32.24%
Negative 3Y CAGR while 3391.T is 25.19%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
331.44%
10Y equity/share CAGR above 1.5x 3391.T's 147.21%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
86.25%
5Y equity/share CAGR above 1.5x 3391.T's 40.48%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.83%
3Y equity/share CAGR above 1.5x 3391.T's 12.42%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
166.67%
Dividend/share CAGR of 166.67% while 3391.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
9.04%
AR growth well above 3391.T's 0.89%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.29%
Inventory is declining while 3391.T stands at 0.46%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.36%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.52%
BV/share growth above 1.5x 3391.T's 0.05%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.02%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-0.62%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.